Cargando…

Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study

BACKGROUND: To understand the current state of insufficient drug efficacy experienced by patients with Parkinson’s disease (PD) and its effects on quality of life (QOL), we conducted a survey of patients with PD and analyzed the results from 2,630 completed questionnaires. METHODS: The questionnaire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsugawa, Jun, Onozawa, Rieko, Fukae, Jiro, Mishima, Takayasu, Fujioka, Shinsuke, Tsuboi, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491278/ https://www.ncbi.nlm.nih.gov/pubmed/26143184 http://dx.doi.org/10.1186/s12883-015-0360-y

Ejemplares similares

The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson’s Disease Patients According to Rome III Diagnostic Criteria
por: Mishima, Takayasu, et al.
Publicado: (2017)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Hospital-based study on emergency admission of patients with Parkinson's disease
por: Fujioka, Shinsuke, et al.
Publicado: (2016)

Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
por: Inoue, Ken-ichi, et al.
Publicado: (2020)

Fluctuating pain in Parkinson's disease: Its prevalence and impact on quality of life
por: Kurihara, Kanako, et al.
Publicado: (2021)

Antiparkinson Prodrugs
por: Di Stefano, Antonio, et al.
Publicado: (2008)

Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria
por: Tsuboi, Yoshio, et al.
Publicado: (2021)

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report
por: Yanamoto, Shozaburo, et al.
Publicado: (2016)

Evaluation of perception threshold and pain in patients with Parkinson’s disease using PainVision(®)
por: Kurihara, Kanako, et al.
Publicado: (2023)

Longstanding IgG4-related Ophthalmic Disease Dramatically Improved after Steroid Therapy
por: Hirata, Yoko, et al.
Publicado: (2018)

Personalized Medicine in Parkinson’s Disease: New Options for Advanced Treatments
por: Mishima, Takayasu, et al.
Publicado: (2021)

Polymyalgia Rheumatica Following COVID-19 Vaccination
por: Yokote, Akira, et al.
Publicado: (2022)

HTLV-1-associated demyelinating neuropathy: A case report and review of the literature
por: Tamaki, Keiko, et al.
Publicado: (2023)

Impact of Parkinson's Disease on Caregiver Quality of Life in Japan
por: Nagaki, Koichi, et al.
Publicado: (2023)

The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
por: Ouma, Shinji, et al.
Publicado: (2017)

Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study
por: Hayashi, Yuka, et al.
Publicado: (2021)

Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
por: Mishima, Takayasu, et al.
Publicado: (2022)

Association between physical activity and health literacy in patients with Parkinson’s disease: an online web survey
por: Nagaki, Koichi, et al.
Publicado: (2023)

National Trends of Antiparkinsonism Treatment in Taiwan: 2004–2011
por: Liu, Weng-Ming, et al.
Publicado: (2016)

Unilateral GPi-DBS Improves Ipsilateral and Axial Motor Symptoms in Parkinson’s Disease as Evidenced by a Brain Perfusion Single Photon Emission Computed Tomography Study
por: Hayashi, Yuka, et al.
Publicado: (2022)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders
por: Kakimoto, Asako, et al.
Publicado: (2022)

Siblings with Cockayne Syndrome B Type III Presenting with Slowly Progressive Cerebellar Ataxia
por: Takahashi, Nobutaka, et al.
Publicado: (2023)

An Analysis of the Activating System Including Its use for Screening Antiparkinson Drugs
por: Himwich, Harold E., et al.
Publicado: (1955)

Dysphagia in Perry Syndrome: Pharyngeal Pressure in Two Cases
por: Umemoto, George, et al.
Publicado: (2017)

A Case of Organophosphate Poisoning Inducing Parkinsonism which was Effectively Treated by Antiparkinson Drugs
por: Yanagawa, Youichi, et al.
Publicado: (2023)

Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease
por: Herrán, Enara, et al.
Publicado: (2014)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

Evaluation of Motor Complications in Parkinson's Disease: Understanding the Perception Gap between Patients and Physicians
por: Ogura, Hiromu, et al.
Publicado: (2021)

A Fatal Case of Neuroleptic Malignant Syndrome After Paralytic Bowel in a Patient Taking Antiparkinson Medication
por: Campa, Domenico, et al.
Publicado: (2016)

Posterior Interosseous Nerve Palsy Caused by a Ganglion
por: Yokote, Akira, et al.
Publicado: (2019)

Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease
por: Kakimoto, Asako, et al.
Publicado: (2023)

Establishing diagnostic criteria for Perry syndrome
por: Mishima, Takayasu, et al.
Publicado: (2018)

Physical Activity and Its Diurnal Fluctuations Vary by Non-Motor Symptoms in Patients with Parkinson’s Disease: An Exploratory Study
por: Nagaki, Koichi, et al.
Publicado: (2022)

Leg Muscle Strength Correlates with Gait Performance in Advanced Parkinson Disease
por: Yokote, Akira, et al.
Publicado: (2021)

Antiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3
por: Sogawa, Chiharu, et al.
Publicado: (2020)

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Tamaki, Keiko, et al.
Publicado: (2019)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
por: Deshimaru, Manami, et al.
Publicado: (2021)

Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases
por: Umemoto, George, et al.
Publicado: (2017)

Impact of Progression of Parkinson's Disease on Swallowing Ability and Oral Environment
por: Umemoto, George, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_46ejqb3siq00tqqdr4f4nmpsh7